Insider sale
HALEON PLC
$3.47M
404.60K shares
What this filing means
GSK MASTER GRANTOR TRUST plans to sell 404.60K shares of HALEON PLC valued at approximately $3.47M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/5/2023ACC: 0001839882-23-032888
404.60K
Shares to sell
$3.47M
Approx. market value
404.60K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
The American Depositary Shares were allocated as part of the spin-off of Haleon plc from GSK plc
N/A
7/18/2022
404.60KTotal acquired404.60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/18/2022 | The American Depositary Shares were allocated as part of the spin-off of Haleon plc from GSK plc N/A | 404.60K | — |
| Total | 404.60K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
404.60K
Market value
$3.47M
12/5/2023
Total
Units
404.60K
Value
$3.47M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/5/2023 | 404.60K | $3.47M | NYSE | Planned |
| Total | 404.60K | $3.47M | ||